On Friday, Pulmonx Corp (NASDAQ: LUNG) opened higher 9.92% from the last session, before settling in for the closing price of $1.31. Price fluctuations for LUNG have ranged from $1.31 to $9.37 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -19.80% over the past five years. Company’s average yearly earnings per share was noted -1.62% at the time writing. With a float of $38.38 million, this company’s outstanding shares have now reached $41.25 million.
Pulmonx Corp (LUNG) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Pulmonx Corp is 11.60%, while institutional ownership is 77.72%. The most recent insider transaction that took place on Sep 02 ’25, was worth 15,437. In this transaction PRESIDENT AND CEO of this company sold 9,648 shares at a rate of $1.60, taking the stock ownership to the 358,967 shares. Before that another transaction happened on Sep 02 ’25, when Company’s Chief Financial Officer & PAO sold 7,936 for $1.60, making the entire transaction worth $12,698. This insider now owns 208,489 shares in total.
Pulmonx Corp (LUNG) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.33 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.45) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.12% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Check out the current performance indicators for Pulmonx Corp (LUNG). In the past quarter, the stock posted a quick ratio of 4.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.41, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.34 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Pulmonx Corp (NASDAQ: LUNG) saw its 5-day average volume 1.03 million, a positive change from its year-to-date volume of 1.02 million. As of the previous 9 days, the stock’s Stochastic %D was 8.93%.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 5.06%, which indicates a significant decrease from 16.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1473 in the past 14 days, which was lower than the 0.1741 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6808, while its 200-day Moving Average is $3.5802. Nevertheless, the first resistance level for the watch stands at $1.4833 in the near term. At $1.5267, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.6083. If the price goes on to break the first support level at $1.3583, it is likely to go to the next support level at $1.2767. Assuming the price breaks the second support level, the third support level stands at $1.2333.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
There are currently 41,247K shares outstanding in the company with a market cap of 59.40 million. Presently, the company’s annual sales total 83,790 K according to its annual income of -56,390 K. Last quarter, the company’s sales amounted to 21,500 K and its income totaled -13,960 K.
